Middle East Respiratory Syndrome--need for increased vigilance and watchful surveillance for MERS-CoV in sub-Saharan Africa

Affiliations

• ¹ Division of Infection and Immunity, University College London, and NIHR Biomedical Research Centre, UCL Hospitals NHS Foundation Trust, London, United Kingdom. Electronic address: a.zumla@ucl.ac.u.
• ² South Africa Medical Research Council, Cape Town, South Africa. Electronic address: Roxana.Rustomjee@mrc.ac.za.
• ³ Fondation Congolaise pour la Recherche Médicale, Brazzaville, Republic of Congo. Electronic address: fntoumi@fcrm-congo.com.
• ⁴ UNZA-UCLMS Research and Training Project, University Teaching Hospital, Lusaka, Zambia. Electronic address: pbmwaba2000@gmail.com.
• ⁵ UNZA-UCLMS Research and Training Project, University Teaching Hospital, Lusaka, Zambia. Electronic address: matthew.bates@ucl.ac.uk.
• ⁶ Therapeutic Immunology, Departments of Laboratory Medicine and Microbiology, Tumour and Cell Biology, Karolinska Institute, Stockholm, Sweden. Electronic address: Markus.Maeurer@ki.se.
• ⁷ Division of Respiratory Medicine and Stanley Ho Center for Emerging Infectious Diseases, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong Special Administrative Region, China. Electronic address: dschui@cuhk.edu.hk.
• ⁸ Department of Infectious Diseases and Clinical Microbiology, Aarhus University Hospital Skejby, Aarhus, Denmark. Electronic address: eskildp@dadlnet.dk.